A new bill in the California legislature, Assembly Bill 418, introduced by Democrat Jesse Gabriel could bring about the first sales ban on Skittles and other confections that use food additives
Assembly Bill 418 aims to prohibit the manufacture, sale, and distribution of any foods containing the additives red dye no. 3, titanium dioxide, potassium bromate, brominated vegetable oil, and propylparaben.
Other than Skittles, brands being called out for additive use includes Just Born Quality Confections, the manufacturer of Peeps.
The additives listed in Assembly Bill 418 are currently classified as safe by the FDA. However, the European Food Safety Authority’s independent study revealed the additives’ risk to consumers, including asthma, cancer, memory loss, impaired coordination, and behavioral issues. The European Union banned the use of additives along with the import and use of any food products that use them.


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Asian Stocks Rise on AI Optimism and Iran Peace Talk Hopes
U.S. Disrupts Russian Military Hackers' Global DNS Hijacking Network
Morgan Stanley Warns Against Overestimating EV Demand Boost from Rising Oil Prices
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
Want to cut your energy bills? Here’s how five experts are doing it
Iran Closes Strait of Hormuz Again After Brief Reopening, Rattling Global Energy Markets
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Asian Currencies Stay Range-Bound as Dollar Holds Steady Ahead of Fed Nominee Hearing
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear
U.S. Stock Futures Fall as Iran Tensions Escalate and Oil Prices Surge
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
The four types of dementia most people don’t know exist
Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 



